See also this year's filing and all EDGAR filings for this company.
PDF Report 0001625288_2020_NEXIEN_BIOPHARMA_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001625288')"} |
Graph
Absolute values for 0001625288, NEXIEN BIOPHARMA INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 310,670 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 44,750 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,668,841 |
| 9 | ResearchAndDevelopmentExpense | 63,858 |
| 10 | remainder_Expenses | 568,214 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 310,670 |
| 1 | Liabilities | 44,750 |
| 2 | Expenses | 4,300,913 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 265,920 |
| 5 | NetIncome | -4,300,913 |
| 6 | ComprehensiveNetIncome | -4,300,913 |
| 7 | BaseVar | 2,328,166 |
| 8 | EconomicCapitalRatio | -21.6 |
Edgar->Model Mapping
Feature Distribution
Change over Time
